Press Releases QuidelOrtho Corporation

Equities

QDEL

US2197981051

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 20:00:00 13/03/2026 GMT			5-day change	1st Jan Change
17.10 ^USD	-4.58%		-17.91%	-40.13%

02-16	QuidelOrtho Corporation Enters Strategic Supply Agreement to Expand Global Immunoassay Portfolio	CI
02-13	Joseph M. Busky to Retire as Principal Financial Officer of Quidelortho Corporation, Effective as of June 30, 2026	CI

Press Releases

02-19	QuidelOrtho : Annual Report for Fiscal Year Ending December 28, 2025 (Form 10-K)	PU
02-18	QuidelOrtho to Present at the 47th Annual Raymond James Institutional Investor Conference	PR
02-11	QuidelOrtho: Q4 Earnings Snapshot	AQ
02-11	QuidelOrtho Reports Fourth Quarter and Full-Year 2025 Financial Results	PR
02-03	QuidelOrtho Receives Excellence Services Label in EMEA and Two Stevie® Awards	PR
01-21	QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results	PR
11-24	QuidelOrtho To Participate In Upcoming Investor Conferences	PR
11-20	The Power of Prevention: Detecting Diabetes Before It Strikes	PU
11-05	QuidelOrtho: Q3 Earnings Snapshot	AQ
11-05	QuidelOrtho Reports Third Quarter 2025 Financial Results	PR
11-03	QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay	PR
22/10/25	QuidelOrtho to Report Third Quarter 2025 Financial Results	PR
23/09/25	QuidelOrtho Announces Availability of QUICKVUE Influenza + SARS Test for Professional Use	AQ
22/09/25	QuidelOrtho Announces Availability of QUICKVUE™ Influenza + SARS Test for Professional Use	PR
28/08/25	QuidelOrtho to Participate in the Baird 2025 Global Healthcare Conference	PR
21/08/25	QuidelOrtho Completes Debt Refinancing	PR
19/08/25	QuidelOrtho Welcomes Erich Wolff as Executive Vice President, Strategy & Corporate Development	PR
05/08/25	QuidelOrtho: Q2 Earnings Snapshot	AQ
05/08/25	QuidelOrtho Reports Second Quarter 2025 Financial Results	PR
22/07/25	QuidelOrtho to Report Second Quarter 2025 Financial Results	PR
14/07/25	QUIDELORTHO AND BÜHLMANN LABORATORIES AG ANNOUNCE AVAILABILITY OF FECAL CALPROTECTIN (FCAL®) TURBO AND FECAL PANCREATIC ELASTASE (FPELA®) TURBO ASSAYS ON VITROS™ SYSTEMS AS A MICROTIP™ PARTNERSHIP ASSAY (MPA)	PR
07/07/25	QuidelOrtho Strengthens Leadership Team With Appointments of Senior Vice Presidents for Global Quality and Clinical & Regulatory Affairs	PR
03/06/25	QuidelOrtho Announces Strategy to Accelerate Growth in Molecular Diagnostics	PR
22/05/25	QuidelOrtho to Participate in Upcoming Investor Conferences	BU
07/05/25	QuidelOrtho: Q1 Earnings Snapshot	AQ